Clinical Trials Sponsored by Chonburi Cancer Hospital

Total 9885 results

Zhejiang Cancer Hospital

Recruiting

A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer

Breast Cancer

China
Hubei Cancer Hospital

Recruiting

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

NSCLC

China
Zhejiang Cancer Hospital

Recruiting

Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer (PAILACC)

Cervical Cancer

China
Zhejiang Cancer Hospital

Not yet recruiting

A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC

Small Cell Lung Cancer Extensive Stage
Zhejiang Cancer Hospital

Not yet recruiting

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery

China
Zhejiang Cancer Hospital

Not yet recruiting

A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma

Chemotherapy Effect | Gray Zone Lymphoma | Relapse/Recurrence
Henan Cancer Hospital

Recruiting

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

NSCLC | Brain Metastases | Leptomeningeal Metastasis

China
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

Advanced Gastric Adenocarcinoma

China
Henan Cancer Hospital

Recruiting

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma | CD79A Gene Mutation | CD79B Gene Mutation

China
Zhejiang Cancer Hospital

Not yet recruiting

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Breast Cancer
Zhejiang Cancer Hospital

Not yet recruiting

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

China
Henan Cancer Hospital

Recruiting

Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

SCLC, Extensive Stage

China
Henan Cancer Hospital

Recruiting

Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer

Breast Cancer,Her2 Positive

China
Henan Cancer Hospital

Recruiting

PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma

Gastric and Esophagogastric Junction Adenocarcinoma

China
Henan Cancer Hospital

Not yet recruiting

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Non-small Cell Lung Cancer Metastatic
Zhejiang Cancer Hospital

Not yet recruiting

Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung
Zhejiang Cancer Hospital

Recruiting

Single Cell Sequencing Analysis of Thymoma

Thymoma

China
Zhejiang Cancer Hospital

Not yet recruiting

Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC (R-helper)

Unresectable Stage III NSCLC
Fujian Cancer Hospital

Not yet recruiting

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Gastric Cancer
Henan Cancer Hospital

Recruiting

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) (HCHTOG1903)

Esophageal Squamous Cell Carcinoma

China
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Henan Cancer Hospital

Recruiting

Study of CT and MR in the Lung Cancer

MRI | Genes | Response | Lung Cancer Squamous Cell | CT

China
Zhejiang Cancer Hospital

Recruiting

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Gastric Adenocarcinoma

China
Barretos Cancer Hospital

Recruiting

Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (INDUCTION)

Locally Advanced Malignant Neoplasm

Brazil
Fujian Cancer Hospital

Recruiting

A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Gastric Cancer Stage III

China
Zhejiang Cancer Hospital

Recruiting

Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma (Neo-DRATEC)

Surgery | Esophageal Carcinoma | Neoadjuvant Chemoradiotherapy

China
Zhejiang Cancer Hospital

Recruiting

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

Neoplasm Metastasis | Nasopharyngeal Cancer

China
Zhejiang Cancer Hospital

Completed

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Henan Cancer Hospital

Completed

Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer

Chemotherapy-induced Nausea and Vomiting

China
Henan Cancer Hospital

Withdrawn

Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients

Stage IV Breast Cancer

China
Henan Cancer Hospital

Withdrawn

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Breast Cancer | HER2-positive Breast Cancer

China
Fujian Cancer Hospital

Enrolling by invitation

Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC

EGFR/ ALK-negative Advanced NSCLC

China
Zhejiang Cancer Hospital

Active, not recruiting

Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study. (NSCLC)

Non-small Cell Lung Cancer | PDL1 Gene Mutation

China
Zhejiang Cancer Hospital

Completed

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Pathological Conditions, Signs and Symptoms

China
Henan Cancer Hospital

Active, not recruiting

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

China
Henan Cancer Hospital

Completed

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Early Breast Cancer

China
Zhejiang Cancer Hospital

Completed

The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy (HFNO)

Hypoxia

China
Zhejiang Cancer Hospital

Active, not recruiting

A Multi-omics-based Metabolic Typing Study of Gastric Cancer

Gastric Cancer | Diagnosis | Multi-omics

China
Zhejiang Cancer Hospital

Active, not recruiting

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC

Lung Cancer, Small Cell

China
Henan Cancer Hospital

Active, not recruiting

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

HER2 Positive Metastatic Breast Cancer

China
Zhejiang Cancer Hospital

Completed

Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

Glioblastoma

China
Hunan Cancer Hospital

Completed

Real World Study on the Efficacy and Safety of Anti-HER2 Therapy

Breast Neoplasms | HER2-positive Breast Cancer

China
Zhejiang Cancer Hospital

Active, not recruiting

Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics

Gastric Cancer | Signet Ring Cell Carcinoma

China
Fujian Cancer Hospital

Enrolling by invitation

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Malignant Melanomas

China
Henan Cancer Hospital

Completed

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

Extensive Disease Small Cell Lung Cancer

China
Henan Cancer Hospital

Completed

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

HER2 Positive Breast Cancer

China
Henan Cancer Hospital

Withdrawn

GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel

Early Breast Cancer

China
Zhejiang Cancer Hospital

Completed

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Endobronchial Metastases | Bronchoesophageal Fistula | General Anesthetic Drug Adverse Reaction

China
Henan Cancer Hospital

Completed

Application of Painting Analysis and Psychotherapy in Children With Bone Tumors

Bone Tumors

China
Hunan Cancer Hospital

Completed

Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer (ACTDNA)

Metastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality

3

Subscribe